Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA

Sarepta Therapeutics (SRPT) Gains 8.5% Off the OpenAugust 9, 2018 9:40 AM Baird Reiterates Outperform on Sarepta Therapeutics (SRPT) August 9, 2018 9:06 AM Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple CNS-targeted Gene Therapy programs and Access to Important Gene TAugust 8, 2018 4:01 PM